Hansa Biopharma announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on May 12, 2021 and has the following composition: Natalie Berner representing Redmile Group, Lotta Sj?berg representing Handelsbanken Fonder and Jannis Kitsakis representing AP4. As the conveyer of the Nomination Committee, Ulf Wiinberg, Chairman of the Board of Directors at Hansa Biopharma will be asked to summon the first meeting in the Nomination Committee.